In today's Pharmalittle roundup, we're reading about Novo Nordisk layoffs, an Amgen discount program, and more.

Novo Nordisk is one of Europe’s largest companies and a global leader in the treatment of two major lifestyle diseases – diabetes and obesity. Read more here.

Novo Nordisk is well-positioned in the obesity drug market, with strong financials and anticipation for its oral Wegovy pill. See why NVO stock is a Buy now.

A federal appeals court dealt a blow Monday to Novo Nordisk A/S when it ruled the US government lawfully selected its insulins for a program that allows the Medicare agency to negotiate their drug ...

Novo Nordisk and Costco have announced a partnership, with plans to sell one-month supplies of Ozempic and Wegovy to members for a cut price.

Barron’s spoke with Dave Moore, executive vice president of U.S. operations, about Wegovy as a pill, rather than an injection.

At $499 a month, the deal will help expand access to Novo Nordisk's weight loss drugs, but doctors say the hugely popular medications will still be out of reach for many who need them.

Danish drugmaker Novo Nordisk said it plans to make its new obesity pill available through telehealth platforms like Ro and WeightWatchers once it gets U.S. approval, Bloomberg News reported on Friday ...

The retail giant has teamed up with manufacturer Novo Nordisk to offer the injectable pens at 50% off for members who have a prescription and are paying out of pocket ...

Novo Nordisk has submitted an application to the FDA seeking approval of Mim8 for the treatment of people with hemophilia A.